Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EXtension of Tablo TrEatmeNt Duration Registry (XTEND)

NCT04912050 is registered in ClinicalTrials.gov with Outset Medical as lead sponsor.

NCT NCT04912050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04912050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EXtension of Tablo TrEatmeNt Duration Registry (XTEND)
Lead sponsor
Outset Medical
Phase
Observational
Overall status
Completed
Start date
May 25, 2021
Completion date
May 31, 2022
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, end stage renal disease (esrd), end stage renal disease on dialysis